News
2d
Sportschosun on MSNProgressive Ovarian Cancer Improves Survival Rate Up To 1.5X With Double Immune Anti-cancer Drug CombinationProfessor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...
Johnson & Johnson’s Q1 2025 earnings reveal growth in sales and EPS, boosted by MedTech and Pharma. Click for my updated look at JNJ and its most recent news.
2d
Los Angeles Magazine on MSNPrenuvo’s Full-Body MRI Scans Show Patients the Whole PictureThe West L.A. clinic enables Angelenos to take a preventative rather than reactive approach to their health by testing for ...
The number of Australian women freezing their eggs is skyrocketing – but the proportion who actually use them is surprising.
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Tuesday, April 15, 2025. Let’s ...
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.
Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...
A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...
Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before ...
Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...
New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results